Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Event, Trade Show

Immunomic Therapeutics' CEO to Participate in Panel at MD Life Sciences' Bio Innovation Conference Meeting 2020


Immunomic Therapeutics, Inc. announced today that it will participate in a panel at the MD Life Sciences Bio Innovation virtual conference in Maryland. On Monday, October 5, Chief Executive Officer at Immunomic, Dr. Bill Hearl, will participate in a panel titled, "Pandemic & Risk Mitigation: A Focus on Preparation & Resiliency" alongside Novavax's President and CEO, Stanley Erck, and Emmes' President, Anne Lindblad.

The Bio Innovation Conference is presented by Maryland Life Sciences, a division of the Maryland Tech Council that is driving the future of life sciences in Maryland. This conference provides a forum for professionals from industry, academia and government to discuss trends and insight into Maryland's burgeoning life sciences industry and topics related to funding, structuring, commercialization and government relations.

Panel details are as follows:

Title: Pandemic & Risk Mitigation: A Focus on Preparation & Resiliency

Panel Category: Life Science Track

Moderators:
Linda Segal, Principal, The McCormick Group
Gayatri Varma, Director, Transactions, Business Development & Licensing, AstraZeneca

Speakers:
Stanley Erck, President and CEO, Novavax
Bill Hearl, Ph.D., CEO, Immunomic Therapeutics
Anne Lindblad, Ph.D., President, Emmes

Panel Date and Time: Monday, October 5, 2020 10:25 AM

Location: MD Life Science Bio Innovation Virtual Event

About Immunomic Therapeutics, Inc.

Immunomic Therapeutics, Inc. (ITI) is a privately-held, clinical stage biotechnology company pioneering the development of vaccines through its proprietary technology platform, UNiversal Intracellular Targeted Expression (UNITE), which is designed to utilize the body's natural biochemistry to develop vaccines that generate broad immune responses. ITI's UNITE platform could potentially have broad therapeutic applications in oncology, including viral antigens, cancer antigens, neoantigens and antigen-derived antibodies as biologics and ITI has built a large pipeline from UNITE with six oncology programs and two allergy programs. ITI has entered into a significant allergy partnership with Astellas Pharma and has formed several academic collaborations with leading Immuno-oncology researchers at Fred Hutchinson Cancer Research Institute, Johns Hopkins University of Medicine, and Duke University. ITI maintains its headquarters in Rockville, Maryland. For more information, please visit www.immunomix.com.


These press releases may also interest you

at 11:46
Alliant Credit Union Welcomes New Members to Board of Directors
Alliant Credit Union, a leader in digital banking and one of the largest credit unions in the nation, announces the appointment of four members to its board of directors. These additions to Alliant's board bring vast expertise spanning from leaders...

at 11:45
ISG to Evaluate Workday Ecosystem Providers
Information Services Group (ISG) , a leading global technology research and advisory firm, has launched a research study examining providers that help customers get the most out of the Workday cloud-based enterprise management platform. The study...

at 11:45
Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older
Vertex Pharmaceuticals today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following...

at 11:45
Prostate Cancer Summit: Unveiling the Latest Strategies to Beat Prostate Cancer
Free Virtual Summit Brings Together Experts to Revolutionize Prostate Cancer Care and Treatment Key Takeaways: The Prostate Cancer Summit is a premier virtual event that aims to empower men with practical knowledge and strategies in their fight...

at 11:30
Using AI to Support Vulnerable Communities: Info-Tech Research Group Publishes New Blueprint for Public Sector
New research from the global research and advisory firm explains the challenges federal departments and agencies face in serving vulnerable communities. In its recently published blueprint, Info-Tech highlights the potential for AI initiatives to...

at 11:30
Corporate Sustainability in Action at Truma
Corporate sustainability is about more than simply putting a recycling bin by the copy machine or a water cooler in the breakroom. It is a company's conscious effort to make environmentally responsible choices at every possible opportunity. That is...

More news about Science and technology...


News published on and distributed by: